Privia Health Group, Inc. $PRVA Stock Holdings Cut by Van Berkom & Associates Inc.

Van Berkom & Associates Inc. cut its holdings in Privia Health Group, Inc. (NASDAQ:PRVA) by 0.7% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,685,410 shares of the company’s stock after selling 26,213 shares during the quarter. Privia Health Group comprises approximately 2.6% of Van Berkom & Associates Inc.’s holdings, making the stock its 10th largest position. Van Berkom & Associates Inc.’s holdings in Privia Health Group were worth $72,566,000 at the end of the most recent quarter.

Other large investors also recently added to or reduced their stakes in the company. BlackRock Inc. acquired a new position in shares of Privia Health Group during the 2nd quarter worth $550,684,000. Rubicon Founders LLC bought a new position in shares of Privia Health Group during the 2nd quarter valued at $153,635,863. Bank of New York Mellon Corp bought a new position in shares of Privia Health Group during the 2nd quarter valued at $74,425,000. Wellington Management Group LLP lifted its stake in shares of Privia Health Group by 850.6% in the 2nd quarter. Wellington Management Group LLP now owns 2,130,289 shares of the company’s stock valued at $54,812,000 after purchasing an additional 1,906,187 shares during the last quarter. Finally, Bank of America Corp DE acquired a new stake in shares of Privia Health Group in the 2nd quarter valued at $36,848,000. 94.48% of the stock is owned by institutional investors.

Privia Health Group Stock Up 0.5%

Shares of Privia Health Group stock opened at $24.54 on Tuesday. Privia Health Group, Inc. has a 12-month low of $18.92 and a 12-month high of $28.82. The stock has a 50 day moving average price of $21.12 and a two-hundred day moving average price of $22.64. The stock has a market capitalization of $3.13 billion, a P/E ratio of 94.39 and a beta of 0.76.

Privia Health Group (NASDAQ:PRVA) last released its quarterly earnings results on Thursday, November 5th. The company reported $0.21 EPS for the quarter, beating analysts’ consensus estimates of $0.09 by $0.12. Privia Health Group had a net margin of 1.19% and a return on equity of 3.52%. The company had revenue of $656.96 million for the quarter, compared to analyst estimates of $610.72 million. During the same quarter last year, the firm posted $0.29 earnings per share. The company’s quarterly revenue was up 13.2% compared to the same quarter last year. Sell-side analysts anticipate that Privia Health Group, Inc. will post 0.27 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on PRVA shares. Weiss Ratings reiterated a “hold (c)” rating on shares of Privia Health Group in a report on Tuesday, September 29th. Zacks Research upgraded Privia Health Group from a “strong sell” rating to a “hold” rating in a report on Wednesday, August 5th. Canaccord Genuity Group raised their target price on Privia Health Group from $32.00 to $33.00 and gave the company a “buy” rating in a report on Friday. Piper Sandler boosted their price target on Privia Health Group from $36.00 to $38.00 and gave the stock an “overweight” rating in a research report on Friday. Finally, Citigroup reiterated a “buy” rating on shares of Privia Health Group in a research note on Thursday, July 23rd. Nine equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat.com, Privia Health Group currently has an average rating of “Moderate Buy” and a consensus target price of $31.25.

Privia Health Group Company Profile

Privia Health Group, Inc is a physician enablement company that partners with independent medical groups, health systems and other providers. Its technology-enabled platform is designed to help physicians manage their practices and deliver coordinated care, while retaining their clinical independence.

The company provides practice management, technology, care coordination and population health services. It also helps providers participate in value-based care arrangements, which tie payments more closely to the quality and efficiency of care.